BioPortfolio Bulletin

  http://www.bioportfolio.co.uk/bulletin_41.htm                          June 1 2004

Pharmaceutical Portfolio Management: Integrated decision-making in marketing and R&D, is a strategic management report that presents a comprehensive overview of effective portfolio management processes, with a focus on better preparing senior management, R&D and marketing executives for integrated decision-making across the organization as a whole. Use this report to improve product lifecycle decisions and ensure the right people are involved in making the right decisions, at the right time.

June Promotion – SAVE £745/€1199/$1199

Purchase the ‘Pharmaceutical Portfolio Management’ report before Friday 11th June 2004, and receive a FREE report of your choice from the list below:

Choose your free report from the list below:

• The Pharmacoeconomics Outlook

• The Pharmaceutical Sales Force Outlook

• Pharmaceutical Regulatory Affairs Outlook

• The Pharmaceutical Industry Paradox

• Pharmaceutical Strategic Alliances

• The Top 12 Pharmaceutical Companies

• The Women’s Health Outloook to 2008

• The Cancer Outlook to 2008

• The Cardiovascular Outlook to 2008

• The CNS Outlook to 2008

• The Antivirals Outlook to 2007

• The DTC Marketing Outlook 2003

• The Biotech Sector in the Post-Genomic Era

• New Cancer Therapeutics

• Pharmaceutical R&D Outsourcing Strategies

• The Lifestyle Drugs Outlook to 2007

• Next Generation Drugs

• Opportunities in R&D

Reuters Business Insight reports are published by Datamonitor, in association with Reuters. Reuters, the sphere logo and Reuters Business Insight are trade marks of the Reuters group of companies around the world and are used by Datamonitor under licence from Reuters.

To order email peter.barfoot@bioportfolio.com or purchase online at:

http://www.bioportfolio.com/cgi-bin/acatalog/Reuters_2003.html#a153 

CNS disorders

Cardiovascular disease

Metabolic and Hormonal disorders

Immunology, Inflammation & Infection

Internal Medicine

Selected publications as well as press releases are then listed on therapeutic channels that match core R&D areas. All information is linked back to original sources of information.

Subscription to this service is $95.00/year per channel.  From the day of your subscription you will receive daily email bulletins specific to your selected channel delivering:

• key journal articles selected by LeadDiscovery's panel of industrial R&D experts

• press releases as they are distributed announcing news on clinical trials, regulatory approvals and product launches

• information on new pharmaceutical reports offering in-depth analysis of your therapeutic area.

Register: http://www.bioportfolio.com/leaddiscovery/daily_update_index.htm 

Also news by publishers, regions, sector - click here!

1) Cancer News:
http://www.bioportfolio.co.uk/news/cancer.shtml
http://www.bioportfolio.co.uk/news/cancer_list.html 

2) Pre-defined web searches covering all cancer conditions - from: 
Abdominal Neoplasms to Zollinger-Ellison
http://www.bioportfolio.co.uk/web/cancer_list.html  

3) Therapeutic Advances - Focus on Oncology:
http://www.bioportfolio.com/LeadDiscovery/targetoncology.htm

4) Oncology Reports:
http://www.bioportfolio.com/cgi-bin/acatalog/Datamonitor_Oncology.html  
http://www.bioportfolio.com/cgi-bin/acatalog/Bioportfolio_RandR_27.html  

5) Leading Cancer Companies - Stock prices
Abgenix to Human Genome - http://www.bioportfolio.com/nasdaq/scroll_cancer.htm 
ILEX Oncology to Vertex - http://www.bioportfolio.com/nasdaq/scroll_cancer2.htm 

6) Directory  of Cancer Companies:
http://www.bioportfolio.com/asp/biokeyword2.asp?profile=cancer 

Contact us:
Editorial and features: peter.barfoot@bioportfolio.com 

Subscriber information:
To subscribe for the BioPortfolio Bulletin in HTML, email:
bioportfolio-subscribe-request@peach.ease.lsoft.com

To unsubscribe, email: bioportfolio-signoff-request@peach.ease.lsoft.com WITH NO SUBJECT.  The system will automatically remove your email address from the list based on your email address.  If your email has changed please email peter.barfoot@bioportfolio.com with a list of your email address and we will manually unsubscribe for you.  Thank you for your understanding.

©2004 BioPortfolio Limited